Clinical trial
An Observational Study of South African Dialysis Patients Treated With Aranesp
NCT01890577 is registered in ClinicalTrials.gov with Amgen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study of South African Dialysis Patients Treated With Aranesp
- Lead sponsor
- Amgen
- Phase
- Observational
- Overall status
- Terminated
- Start date
- April 30, 2013
- Completion date
- January 31, 2014
- Enrollment
- 28 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease, receiving dialysis